Evidence-Based Research in Complementary and Alternative Medicine III: Treatment of Patients with Alzheimer's Disease
- PMID: 17173104
- PMCID: PMC1697743
- DOI: 10.1093/ecam/nel072
Evidence-Based Research in Complementary and Alternative Medicine III: Treatment of Patients with Alzheimer's Disease
Abstract
This paper presents the novel domain of evidence-based research (EBR) in the treatment of patients with Alzheimer's disease (AD) from the perspective of traditional medicine and of complementary and alternative medicine. In earlier lectures we have described the process of evidence-based medicine as a methodological approach to clinical practice that is directed to aid clinical decision-making. Here, we present a practical example of this approach with respect to traditional pharmacological interventions and to complementary and alternative treatments for patients with AD.
Figures





References
-
- Scacchi R, Gambina G, Ruggeri M, Martini MC, Ferrari G, Silvestri M, et al. Plasma levels of apolipoprotein E and genetic markers in elderly patients with Alzheimer's disease. Neurosci Lett. 1999;259:33–6. - PubMed
-
- Roses AD. Apolipoprotein E affects the rate of Alzheimer's disease expression: Beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol. 1994;53:429–37. - PubMed
-
- Little JW. Dental management of patients with Alzheimer' disease. Gen Dent. 2005;53:289–96. - PubMed
-
- Evans DA. Estimated prevalence of Alzheimer's disease in the United States. Milbank Q. 1990;68:267–89. - PubMed
-
- Hendrie HC. Epidemiology of Alzheimer's disease. Geriatrics. 1997;52:S4–8. - PubMed